Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
DOI: 10.1369/jhc.4A6500.2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elangbam, C. S.
Right arrow Articles by Wall, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elangbam, C. S.
Right arrow Articles by Wall, H. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry
Volume 53 (5): 671-677, 2005
Copyright ©The Histochemical Society, Inc.

5-Hydroxytryptamine (5HT) Receptors in the Heart Valves of Cynomolgus Monkeys and Sprague-Dawley Rats

Chandikumar S. Elangbam, Ruth M. Lightfoot, Lawrence W. Yoon, Donald R. Creech, Robert S. Geske, Christopher W. Crumbley, Lisa D. Gates and Henry G. Wall

Pathology (CSE,HGW,LDG), Safety Assessment (RML), Investigative Toxicology and Pathology (LWY,DRC), and Quantitative Expression and Genomic Histology (RSG,CWC), GlaxoSmithKline Inc., Research Triangle Park, North Carolina

Correspondence to: C.S. Elangbam, PhD, DACVP, DABT Director, Pathophysiology, Pathology Department, Room 9:3010, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709. E-mail: chandi.s.elangbam{at}gsk.com

5-Hydroxytryptamine-2B receptor (5HT2BR) stimulation is known to cause fibroblast mitogenesis, and the mitogenic effect has been proposed to trigger valvular heart disease in humans. In this study, we used real-time polymerase chain reaction (TaqMan) to quantify transcript levels of 5HT2B, 5HT2C, and 5HT1B receptors and immunohistochemistry (IHC) to detect the tissue localization of these receptors in the normal heart valves of cynomolgus (CM) monkeys and Sprague-Dawley (S-D) rats. In both species, positive immunostaining was noted for 5HT1B and 5HT2B receptors in mitral, tricuspid, aortic, and pulmonary valves, and the cell types showing positive staining were interstitial cells and endothelial cells lining the valve leaflet. In CM monkeys, 5HT2CR was expressed only in the endothelial cells lining the leaflet, whereas S-D valves were negative for this receptor. IHC results were correlated with 5HT2B and 5HT1B receptor transcripts for all four valves. However, 5HT2C receptor transcripts were lower than 5HT2B or 5HT1B in all CM monkey valves, whereas 5HT2C transcripts were below the level of detection in any of the S-D rat valves. Our data showed the expression of 5HT2B, 5HT1B, and 5HT2C receptors in the normal heart valves of CM monkeys and S-D rats, and IHC and TaqMan techniques may be used to study the potential mechanism of compounds with 5HT2BR agonist activity.

(J Histochem Cytochem 53:671–677, 2005)

Key Words: heart valve • 5-hydroxytryptamine (5HT) • receptor • immunohistochemistry • TaqMan • cynomolgus monkey • Sprague-Dawley rat


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
M. A. Gilchrist, A. Cacace, and D. G. Harden
Characterization of the 5-HT2b Receptor in Evaluation of Aequorin Detection of Calcium Mobilization for Miniaturized GPCR High-Throughput Screening
J Biomol Screen, July 1, 2008; 13(6): 486 - 493.
[Abstract] [PDF]


Home page
CirculationHome page
R. J. Levy
Serotonin Transporter Mechanisms and Cardiac Disease
Circulation, January 3, 2006; 113(1): 2 - 4.
[Full Text] [PDF]


Home page
Mol. Interv.Home page
K. J. Miller
SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY
Mol. Interv., October 1, 2005; 5(5): 282 - 291.
[Abstract] [Full Text] [PDF]




Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2005